The Foundation for Neglected Disease Research (FNDR) announced a groundbreaking achievement in tuberculosis (TB) treatment as its partners, Bill & Melinda Gates Medical Research Institute and TB Alliance, concluded the Phase 2A Early Bactericidal Activity clinical trial for TBA-7371.